Trial Profile
Insulin aspart/insulin protamine aspart vs insulin glargine in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin + glimepiride
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2013
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Glimepiride; Insulin glargine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Feb 2013 New trial record